Axially substitutive silicon phthalocyanine complex and doxorubicin conjugate thereof
A silicon phthalocyanine complex technology, applied in the field of axially substituted silicon phthalocyanine complexes and doxorubicin conjugates, can solve the problems of high skin phototoxicity, clinical application limitations, and unstable composition of the mixture. Achieve the effect of high cancer cell uptake rate and excellent amphiphilicity
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Example Embodiment
[0039] The preparation method of the axial end dipeptide substituted silicon phthalocyanine of formula (2.1-2.2) includes the following steps:
[0040] 1) Using axial terminal carboxyl substituted silicon phthalocyanine and N-hydroxysuccinimide as reactants, using N,N-dimethylformamide as solvent, in 1-ethyl-(3-dimethylaminopropyl) In the presence of carbodiimide hydrochloride and under the protection of nitrogen, the reaction is stirred at -5~5°C for 1~2 hours, and then the reaction is stirred at room temperature~35°C for 12~36 hours, and then separated by column chromatography. The silicon phthalocyanine carboxyl activator is obtained; wherein the molar ratio of the axial terminal carboxyl substituted silicon phthalocyanine to the N-hydroxysuccinimide is 1:1.5~5, and the axial terminal carboxyl substituted silicon phthalocyanine is the axial end Carboxyl disubstituted silicon phthalocyanine Or axial asymmetric monocarboxyl substituted silicon phthalocyanine ; The amount of 1-...
Example Embodiment
[0053] Example 1
[0054] 2-[4-(2-aminoethyl)phenoxy]silicon phthalocyanine Synthesis
[0055] According to the published patent method (ZL201210155097.4), the specific steps are as follows:
[0056] Under the protection of nitrogen, add dichlorophthalocyanine silicon (244.7mg, 0.4mmol), 4-(2-aminoethyl)phenol 1.2~2mmol (preferably 1.6mmol) and NaH into 20~50mL toluene or xylene or two In oxane (preferably toluene, 30mL), reflux for 12~24 hours (preferably 18 hours); vacuum rotary evaporation to remove the solvent, use 100mL of dichloromethane to dissolve, centrifuge to remove insolubles, and extract the dichloromethane solution with water (3×100mL) ), collect the organic layer, then extract with dilute hydrochloric acid (0.1~0.5mmol), collect the water layer; neutralize the water layer with 1M sodium hydroxide, precipitate a blue precipitate, centrifuge, wash with water, and dry in vacuo to obtain a blue product, The rate is 45%. The maximum absorption peak of the product in DMS...
Example Embodiment
[0057] Example 2
[0058] Axially asymmetric monocarboxyl substituted silicon phthalocyanine Synthesis
[0059] According to the published application patent (ZL201410108985.X) for synthesis, the specific steps are as follows:
[0060] Under the protection of nitrogen, add dichlorosilicon phthalocyanine (100mg, 0.164mmol), p-hydroxyphenylpropionic acid (1.640~3.280mmol, preferably 4.920mmol) and NaH (0.01~0.02mmol, preferably 0.016mmol) to 7~15mL In toluene (preferably 10 mL), reflux for 12 to 24 hours (preferably 12 hours). The solvent was removed by vacuum rotary evaporation and washed with water to obtain a blue crude product; the crude product was dissolved in tetrahydrofuran, filtered to remove insolubles, and then purified by silica gel column using ethyl acetate: tetrahydrofuran (1:1, v / v) as eluent The second component was collected, concentrated and dried to obtain a blue product with a yield of 35.00%. The maximum absorption peak of the product in DMF is located at 683n...
PUM
Property | Measurement | Unit |
---|---|---|
Wavelength | aaaaa | aaaaa |
Molar absorptivity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap